The insider sales are small relative to market cap and involve a director and a CBO, not the CEO/CFO. Monitor for any upcoming material news (e.g., clinical data, partnership) that could explain the timing, but no immediate action warranted.
Price Chart
Executive Summary
Two insiders at Immunome sold a total of $2.54M in shares over a week, led by the Chief Business Officer's $2.27M sale. Director Isaac Barchas also sold $264K. While the dollar amount is modest relative to the $3.0B market cap (~0.08%), the cluster includes a C-suite officer selling a large block, which warrants attention. The historical calibration shows weak predictive power for insider sales clusters, and the stock has been volatile with mixed prior signal outcomes, so the signal is neutral overall.
Key Financial Metrics
Key Facts
- Chief Business Officer Horn Kinney sold 90.6K shares for $2.27M on 2026-08-04.
- Director Isaac Barchas sold 10.1K shares for $264K on 2026-08-10.
- Total insider sales in the cluster: $2.54M, or ~0.08% of market cap.
- The cluster includes a C-suite officer, but insider sales are weak predictors per academic literature.
- Historical calibration shows cluster sales have not been reliable signals for IMNM.
Financial Impact
Total insider sales of $2.54M represent ~0.08% of the $3.0B market cap, a trivial amount.
Risk Factors
- Insider sales could precede negative news, though the dollar amount is small.
- Stock has been volatile with mixed prior signal outcomes; avoid over-interpreting this cluster.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-IMNM-1786572087189 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 1, 2026 1d ago | ANALYST-UPGRADE | $21.58 awaiting T+5 | awaiting T+5 | — | $20.97 (−2.85%) |
Sep 21, 2026 11d ago | ANALYST-UPGRADE | $25.07 $21.68 | ▼ −13.52% | ▼ −13.24% | $20.97 (−16.37%) |
Aug 12, 2026 7w ago | Insider Cluster | $26.42 $28.08 | ▲ +6.28% | ▲ +8.25% | $20.97 (−20.65%) |
Aug 10, 2026 7w ago | Insider Cluster | $26.25 $27.56 | ▲ +4.99% | ▲ +5.39% | $20.97 (−20.13%) |
Jul 9, 2026 12w ago | Insider Cluster | $23.35 $22.20 | ▼ −4.93% | ▼ −4.36% | $20.97 (−10.21%) |
Jul 7, 2026 12w ago | Insider Cluster | $24.01 $22.59 | ▼ −5.91% | ▼ −6.78% | $20.97 (−12.68%) |
Jul 7, 2026 12w ago | Insider Cluster | $24.01 $22.59 | ▼ −5.91% | ▼ −6.78% | $20.97 (−12.68%) |
Jul 3, 2026 13w ago | Insider Cluster | $23.61 $24.17 | ▼ −2.37% | ▼ −1.44% | $20.97 (+11.20%) |
May 28, 2026 18w ago | ANALYST-UPGRADE | $22.54 $19.81 | ▼ −12.11% | ▼ −12.06% | $20.97 (−6.99%) |
May 12, 2026 20w ago | 8-K | $22.20 $19.66 | ▼ −11.44% | ▼ −10.28% | $20.97 (−5.56%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access